New asthma shot aims to tame severe attacks
NCT ID NCT07342803
First seen Jan 20, 2026 · Last updated Apr 03, 2026 · Updated 10 times
Summary
This study is testing an investigational injection called LP-003 for adults with moderate to severe allergic asthma that isn't fully controlled with standard inhalers. The goal is to see if the injection can reduce the number of asthma flare-ups, improve breathing, and enhance quality of life compared to a placebo or an existing drug. About 200 participants will receive injections and be monitored for safety and effectiveness over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.